Center for Medicine in the Public Interest

From Wikipedia, the free encyclopedia
Jump to: navigation, search

The Center for Medicine in the Public Interest (CMPI) is a non-profit medical issues research group.[1] It was founded by the Pacific Research Institute.[2] CMPI's research agenda deals with clinical outcomes and econometric studies that analyze the value of new medicines and genomic and molecular-based medical innovation.

CMPI is a 501(c)3 organization and as such is not permitted to devote a substantial part of its activity to lobbying. Its officers have written articles on various issues including price controls on pharmaceutical products in publicly funded healthcare schemes in the United States,[3] and restrictions on advertising in the European Union.[4] The Economist Intelligence Unit has written that the organisation generally takes a pro-drug industry viewpoint.[5]

Personnel[edit]

CMPI was founded by Peter Pitts, former FDA Associate Commissioner for External Relations under the Bush administration, and Dr. Robert Goldberg, former fellow at the Manhattan Institute.[6]

CMPI Senior Fellows include:

  • Marc Siegel
  • Doug Badger
  • John F. P. Bridges
  • Jacob Arfwedson

Funding[edit]

Funders include PhRMA and Pfizer.[7]

Reports[edit]

CMPI has published studies on the value of new cancer drugs, the cost-effectiveness of certain Alzheimer's treatments, evidence-based medicine, drug counterfeiting[8] and healthcare terrorism.

References[edit]

  1. ^ Herper, Matthew (2007-07-25). "The Nissen Doctrine". Forbes. Retrieved 2008-01-14. 
  2. ^ Lee Fang (Nov 18, 2009). "Exclusive: Attacks On Health Reform Orchestrated By Yet Another Shadowy Corporate Front Group — ‘CMPI’". Center for American Progress. Retrieved 19 November 2009. 
  3. ^ Goldberg, Robert (2006-12-25). "HillaryCare Comes Back". The Weekly Standard (News America Incorporated). Retrieved 2008-01-14. 
  4. ^ Pitts, Peter J. (2006-04-12). "Power to the Patients". Wall Street Journal. Retrieved 2008-01-14. 
  5. ^ "USA healthcare: FDA centenary prompts politicking". Economist Intelligence Unit (Economist Group). 2006-07-05. Retrieved 2008-01-14. 
  6. ^ Jason Lee Miller (2008-08-01). "Are Google Results Hazardous To Your Health?". WebProNews. iEntry, Inc. Retrieved 2008-01-14. 
  7. ^ http://www.politico.com/news/stories/0708/11570.html
  8. ^ Laurie Sullivan (2006-06-13). "Pharmaceuticals Slowly Adopting RFID To Protect Prescription Drug Supplies". Information Week. CMP Media LLC. Retrieved 2008-01-14. 

External links[edit]